Victory Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$87.8K Sell
16,530
-42,063
-72% -$223K ﹤0.01% 2339
2025
Q1
$520K Sell
58,593
-2,748
-4% -$24.4K ﹤0.01% 2023
2024
Q4
$841K Buy
61,341
+3,711
+6% +$50.9K ﹤0.01% 1876
2024
Q3
$1.58M Sell
57,630
-2,167
-4% -$59.4K ﹤0.01% 1566
2024
Q2
$1.46M Sell
59,797
-3,780
-6% -$92.5K ﹤0.01% 1543
2024
Q1
$1.36M Sell
63,577
-21,010
-25% -$448K ﹤0.01% 1597
2023
Q4
$1.62M Buy
84,587
+24,386
+41% +$467K ﹤0.01% 1498
2023
Q3
$966K Buy
60,201
+912
+2% +$14.6K ﹤0.01% 1671
2023
Q2
$1.37M Buy
59,289
+79
+0.1% +$1.83K ﹤0.01% 1523
2023
Q1
$1.38M Buy
59,210
+246
+0.4% +$5.72K ﹤0.01% 1532
2022
Q4
$856K Sell
58,964
-1,782
-3% -$25.9K ﹤0.01% 1812
2022
Q3
$1.16M Buy
60,746
+9,899
+19% +$189K ﹤0.01% 1667
2022
Q2
$924K Buy
50,847
+1,469
+3% +$26.7K ﹤0.01% 1785
2022
Q1
$1.01M Buy
49,378
+9,691
+24% +$199K ﹤0.01% 1809
2021
Q4
$1.1M Buy
39,687
+14,145
+55% +$390K ﹤0.01% 1798
2021
Q3
$825K Sell
25,542
-1,885
-7% -$60.9K ﹤0.01% 1941
2021
Q2
$839K Buy
27,427
+7,779
+40% +$238K ﹤0.01% 1955
2021
Q1
$598K Buy
19,648
+8,938
+83% +$272K ﹤0.01% 2113
2020
Q4
$212K Buy
+10,710
New +$212K ﹤0.01% 2363
2020
Q2
Sell
-32,404
Closed -$464K 2983
2020
Q1
$464K Buy
32,404
+16,962
+110% +$243K ﹤0.01% 2118
2019
Q4
$420K Buy
15,442
+2,664
+21% +$72.5K ﹤0.01% 2088
2019
Q3
$366K Buy
+12,778
New +$366K ﹤0.01% 2003
2018
Q3
Sell
-7,274
Closed -$272K 1849
2018
Q2
$272K Buy
7,274
+1,000
+16% +$37.4K ﹤0.01% 1558
2018
Q1
$185K Buy
+6,274
New +$185K ﹤0.01% 1617
2017
Q1
Sell
-2,667
Closed -$44K 1837
2016
Q4
$44K Sell
2,667
-66
-2% -$1.09K ﹤0.01% 1720
2016
Q3
$56K Buy
2,733
+735
+37% +$15.1K ﹤0.01% 1696
2016
Q2
$61K Buy
1,998
+870
+77% +$26.6K ﹤0.01% 1466
2016
Q1
$42K Sell
1,128
-532
-32% -$19.8K ﹤0.01% 1459
2015
Q4
$72K Sell
1,660
-54
-3% -$2.34K ﹤0.01% 1462
2015
Q3
$64K Buy
1,714
+13
+0.8% +$485 ﹤0.01% 1411
2015
Q2
$58K Buy
+1,701
New +$58K ﹤0.01% 1445